EURACTIV HealthAug 26, 2024
Congo turns to Belgian pharma company for mpox rapid antigen tests [Advocacy Lab Content] https://www.euractiv.com/section/health-consumers/news/congo-turns-to-belgian-pharma-company-for-mpox-rapid-antigen-tests/?utm_source=dlvr.it&utm_medium=mastodon #Belgium #biotechnlogy #DRC #mpox #Virus
Congo turns to Belgian pharma company for mpox rapid antigen tests

The Democratic Republic of Congo has ordered one million rapid antigen tests from the Belgian pharmaceutical c

EURACTIV
EURACTIV TechnologyFeb 8, 2024
German government provides additional funding for tech start-ups https://www.euractiv.com/section/digital/news/german-government-provides-additional-funding-for-tech-start-ups/?utm_source=dlvr.it&utm_medium=mastodon #artificialintelligence #biotechnlogy #BMWK #climatetechnology
German government provides additional funding for tech start-ups

The German government plans to support local tech start-ups with €1.75 billion but experts point out the env

EURACTIV
Alan KotokJun 1, 2023

Clinical Trial Begins for Peanut Allergy Treatment

A clinical trial is underway testing an experimental therapy for #peanut #allergy that its developer says trains the #immune system without using peanut #proteins.

https://sciencebusiness.technewslit.com/?p=44849

#News #Science #Business #Biotechnlogy #ClinicalTrial #Immunology #TCells #Peptides #Chemistry #Allergens #Anaphylaxis #Australia

Clinical Trial Begins for Peanut Allergy Treatment

A clinical trial is underway testing an experimental therapy for peanut allergy that its developer says trains the immune system without using peanut proteins.

Science and Enterprise